Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLN.SW Stock Summary
Top 10 Correlated ETFs
CLN.SW
In the News
CLN.SW Financial details
Company Rating
Strong Buy
Market Cap
4.35B
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
0.42
Dividend %
3.21%
Employees
10.69K
Optionable
No
Shortable
Yes
Earnings
30 Oct 2023
P/E
-42.6
Forward P/E
-
PEG
-
P/S
0.83
P/B
1.84
P/C
-
P/FCF
14.83
Quick Ratio
0.41
Current Ratio
1.43
Debt / Equity
0.52
LT Debt / Equity
0.38
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-129.81%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-4.73%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-13.33%
SMA100
-
Inst Own
0.01%
Inst Trans
1%
ROA
-2%
ROE
-4%
ROC
0.02%
Gross Margin
20%
Oper. Margin
1%
Profit Margin
-2%
Payout
-131%
Shs Outstand
329.02M
Shs Float
204.94M
-
-
-
-
Target Price
-
52W Range
12.07-16.29
52W High
-18.31%
52W Low
+8.92%
RSI
45
Rel Volume
0.81
Avg Volume
728.86K
Volume
590.99K
Perf Week
-1.95%
Perf Month
-0.08%
Perf Quarter
-0.53%
Perf Half Y
-2.32%
-
-
-
-
Beta
0.902
-
-
Volatility
0.08%, 0.4%
Prev Close
0.69%
Price
13.07
Change
0.93%
CLN.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 20.09 | 13.35 | 11.71 | 13.28 | 15.79 | |
Net income per share | 1.02 | -0.1 | 0.35 | 1.04 | -0.31 | |
Operating cash flow per share | 1.61 | 1.54 | 1.12 | 1.1 | 1.53 | |
Free cash flow per share | 0.83 | 0.67 | 0.21 | 0.01 | 0.88 | |
Cash per share | 2.81 | 3.05 | 3.2 | 1.45 | 2.3 | |
Book value per share | 8.49 | 7.6 | 6.8 | 7.16 | 7.11 | |
Tangible book value per share | 3.91 | 4.02 | 3.47 | 3.84 | 4.61 | |
Share holders equity per share | 8.49 | 7.6 | 6.8 | 7.16 | 7.11 | |
Interest debt per share | 7.06 | 7.24 | 6.35 | 6.11 | 4.61 | |
Market cap | 5.96B | 7.12B | 6.2B | 6.26B | 4.82B | |
Enterprise value | 7.37B | 8.77B | 7.49B | 7.79B | 5.89B | |
P/E ratio | 17.69 | -209.39 | 53.46 | 18.19 | -47.75 | |
Price to sales ratio | 0.9 | 1.62 | 1.61 | 1.43 | 0.93 | |
POCF ratio | 11.25 | 13.99 | 16.81 | 17.24 | 9.61 | |
PFCF ratio | 21.84 | 32.36 | 88.59 | 2.09K | 16.63 | |
P/B Ratio | 2.13 | 2.84 | 2.77 | 2.65 | 2.06 | |
PTB ratio | 2.13 | 2.84 | 2.77 | 2.65 | 2.06 | |
EV to sales | 1.11 | 1.99 | 1.94 | 1.78 | 1.13 | |
Enterprise value over EBITDA | 8.39 | 17.65 | 13.54 | 10.78 | 17.48 | |
EV to operating cash flow | 13.91 | 17.23 | 20.29 | 21.46 | 11.74 | |
EV to free cash flow | 27 | 39.86 | 106.95 | 2.6K | 20.32 | |
Earnings yield | 0.06 | 0 | 0.02 | 0.05 | -0.02 | |
Free cash flow yield | 0.05 | 0.03 | 0.01 | 0 | 0.06 | |
Debt to equity | 0.8 | 0.91 | 0.9 | 0.83 | 0.63 | |
Debt to assets | 0.28 | 0.29 | 0.29 | 0.28 | 0.24 | |
Net debt to EBITDA | 1.6 | 3.32 | 2.32 | 2.12 | 3.18 | |
Current ratio | 1.47 | 1.49 | 1.6 | 1.23 | 1.43 | |
Interest coverage | 6.2 | 1.72 | 4.14 | 7.1 | 1.31 | |
Income quality | 1.49 | 13.39 | 0.46 | 0.97 | 4.33 | |
Dividend Yield | 0.03 | 0.03 | 0.16 | 0.04 | 0.03 | |
Payout ratio | 0.49 | -5.32 | 8.53 | 0.67 | -1.31 | |
Sales general and administrative to revenue | 0.2 | 0.24 | 0.19 | 0.17 | 0.16 | |
Research and developement to revenue | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | |
Intangibles to total assets | 0.21 | 0.17 | 0.18 | 0.18 | 0.16 | |
Capex to operating cash flow | -0.48 | -0.57 | -0.81 | -0.99 | -0.42 | |
Capex to revenue | -0.04 | -0.07 | -0.08 | -0.08 | -0.04 | |
Capex to depreciation | -0.79 | -0.88 | -1.11 | -1.35 | -0.77 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 13.97 | 4.2 | 7.34 | 12.97 | 7.01 | |
ROIC | 0.08 | -0.02 | 0.04 | 0.07 | -0.3 | |
Return on tangible assets | 0.05 | -0.01 | 0.02 | 0.06 | -0.02 | |
Graham Net | -10.85 | -6.53 | -5.85 | -6.78 | -7.65 | |
Working capital | 1.06B | 1.32B | 1.23B | 569M | 808M | |
Tangible asset value | 1.29B | 1.33B | 1.14B | 1.26B | 1.52B | |
Net current asset value | -1.67B | -1.28B | -1.26B | -1.46B | -1.01B | |
Invested capital | 0.8 | 0.91 | 0.9 | 0.83 | 0.63 | |
Average receivables | 0 | 1.21B | 2.08B | 1.83B | 960M | |
Average payables | 753M | 727M | 621.5M | 613.5M | 624M | |
Average inventory | 985M | 834.5M | 592.5M | 612.5M | 743.5M | |
Days sales outstanding | 0 | 201.29 | 164.25 | 160.29 | 0 | |
Days payables outstanding | 58.37 | 84.97 | 73.22 | 81.61 | 48.98 | |
Days of inventory on hand | 79.23 | 78.58 | 72.54 | 81.97 | 69.62 | |
Receivables turnover | 0 | 1.81 | 2.22 | 2.28 | 0 | |
Payables turnover | 6.25 | 4.3 | 4.99 | 4.47 | 7.45 | |
Inventory turnover | 4.61 | 4.65 | 5.03 | 4.45 | 5.24 | |
ROE | 0.12 | -0.01 | 0.05 | 0.15 | -0.04 | |
Capex per share | -0.78 | -0.88 | -0.91 | -1.09 | -0.64 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-09-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 383.5M | 1.53B | 1.2B | 1.07B | 953M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.38 | 0.83 | 0.57 | 0.63 | 0.52 | |
Debt to assets | 0.14 | 0.28 | 0.23 | 0.24 | 0.22 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.23 | 1.23 | 1.27 | 1.43 | 1.53 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.18 | 0.18 | 0.19 | 0.16 | 0.17 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 142.25M | 569M | 592M | 808M | 765M | |
Tangible asset value | 316M | 1.26B | 1.65B | 1.52B | 1.58B | |
Net current asset value | -363.75M | -1.46B | -1.11B | -1.01B | -911M | |
Invested capital | 0.38 | 0.83 | 0.57 | 0.63 | 0.52 | |
Average receivables | 815M | 960M | 0 | 0 | 0 | |
Average payables | 634.5M | 430M | 0 | 0 | 0 | |
Average inventory | 444.88M | 431.88M | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CLN.SW Frequently Asked Questions
What is Clariant AG stock symbol ?
Clariant AG is a CH stock and trading under the symbol CLN.SW
What is Clariant AG stock quote today ?
Clariant AG stock price is $13.07 today.
Is Clariant AG stock public?
Yes, Clariant AG is a publicly traded company.